Friday, May 20, 2011

Recommendation: bring a shotgun to the interview

From ACS Careers:
Brains for chemical biology - tenure track position
Job description The Donders Institute for Brain Cognition and behavior (DI) at Radboud University Nijmegen (Netherlands) is pleased to offer a tenure track position in the field of Chemical Biology. Chemical Biology is one of the top research priorities in Nijmegen and the DCN. This highly collaborative environment offers exceptional research opportunities to independent, motivated and gifted scientists. 
You are encouraged to launch your own independent research programme within the DI, which should be in line with one of the research themes listed below. Furthermore you are expected to publish in high-profile journals, attract your own external funding, and contribute to the teaching programmes of the Faculty of Science.
Within the DI’s chemical biology initiative one tenure track position is vacant on the following theme: 
Probing of cellular processes is highly relevant in the field of neuroscience. Chemical biology tools need to be constructed to image these processes on a cellular, and even molecular level. Smart viral delivery systems for genes that code for ion-specific proteins will thus enable the expression of channels and pumps in neuronal cells, which can be switched on and off with a tunable laser and thereby utilized in optogenetics studies.
I mean, sure, this could be the Netherland's most prominent universities with an excellent quality of life. Or, it could be a secret hideout of zombies and their human collaborators. Anybody that's advertising for braaaaaaaaains is subject to suspicion in times like these. 

Thursday, May 19, 2011

That's a lot of clams to be a salesperson

From LinkedIn, another data point in the "working for scientific equipment manufacturers" discussion in the comments of the plumber post:
My client is a highly respected, well known manufacturer of scientific instrumentation and consumables serving researchers at pharma and biotech companies, as well as scientists at academic and government research institutions. This client is looking to hire a San Francisco or San Diego based Sales Rep to cover CA, AZ, and NV. Overnight travel is estimated at around 30-50%. 
Requirements:
  • BS/BA degree in Chemistry (or related) is strongly preferred but applicable work experience could be substituted
  • Understanding of Organic Chemistry is preferred but not required 
  • Experience in sales or a customer facing role (Field Applications Scientist, Technical Specialist, etc)
  • Preference for capital equipment sales (equipment over 10k)
  • Excellent interpersonal, communication, and presentation skills
  • Ability and willingness to perform the required travel 
  • Ability and willingness to perform some of your own lead generation
Compensation:
The position offers a base salary + total comp of anywhere from 90-115k, depending on the base salary you receive and overall performance. Candidates seeking a total comp package at plan of up to 120k are encouraged to apply. The position also includes a car allowance, home office set-up, and complete benefits package. 
Uh, wow. That sounds like a lot of money*; of course, it is sales, where you're working your butt off and trying to interact with people. It is this latter item that I suspect most chemists just don't have the stomach for (I know I don't.) Best of luck to those who are interested (click through for contact info.)

*You could also argue that someone is exaggerating; that, of course, might be overly cynical.

Daily Pump Trap: 5/19/11 edition

Good morning! Between May 17 and May 18, there were 11 new positions posted on the ACS Careers website. Of these, 2 (18%) are academically connected and 1 (9%) is from Kelly Scientific Resources.

Safety: Arkema is looking for a senior product safety specialist; B.S. in chemistry and 5 years in product safety regulation desired.

Polymers: PPG Industries is looking for a Ph.D. chemist; polymer synthesis experience, the ability to supervise a technician (?) and the ability to pass a hair sample drug test (?!?) is desired.

Burlington!: Seventh Generation is looking for a B.S. chemist to become their research manager; 5 years in product development (hopefully in home cleaning products) is desired.

A broader look: Seems I'm doing more and more of these, as the ACS Careers feed starts drying up (and the Merck ads don't roll in.) Monster.com, Careerbuilder.com and Indeed.com show (respectively) 303, 709 and 4,268 positions for the search term "chemist." USAjobs.gov shows 88 positions for the search term "chemist." 

Wednesday, May 18, 2011

9 inch pipettes

A (long?) list of small, useful things (links):

Process Wednesday: no special solvent for you!

Want to buy that super-duper ultra pure solvent for your reaction in the lab? Our mentor-by-literature, Neal Anderson, says you're out of luck, bucko (from pg. 102 of  "Practical Process Research and Development"):
For initial laboratory investigations, whenever possible use solvents from bulk supplies that have been purchased for routine processing. Avoid special grades of solvents, such as HPLC-grade solvents, as processing may changes when reactions are run in bulk solvents, due to differing impurities and impurity levels.  
Using a higher grade of solvent may not be necessary. [snip] Once a special grade of solvent has been shown to be necessary, the purchase of the more costly material is readily justified. 
Well, drat. So unless you're willing to purchase that super-duper ultra pure grade by the rail car (hopefully you'll be buying it by the rail car, anyway), you're better off with the normal stuff.

Tuesday, May 17, 2011

Chemist versus plumber


Lots more chemists in the past; lots more plumbers overall. Thanks to Job Voyager for the comparison. 

Daily Pump Trap: 5/17/11 edition

Good morning! Between May 12 and May 16, there were 23 new positions posted on the ACS Careers website. Of these, 4 (17%) are academically connected.

Slowing down a lot: I suspect that we're in the summer 'fallow' period. Things will probably pick up again in mid-July.

Oh, you again: Neurocrine Biosciences is a biotech in San Diego; as I recall, they laid off a good portion of their medicinal chemistry staff some years ago. That being said, they're looking for an experienced Ph.D. chemist to be their director of chemical development. Eight years experience in the pharmaceutical field desired. Hopefully, this is good news for them.

And you, too: Intrexon is still looking for that position for a M.S./Ph.D. chemist to perform scale-ups of internal R&D compounds. Why the resubmit?

Breathe free: Assay Technologies (Boardman, OH) manufactures personal monitoring badges for chemicals. They're looking for a B.S./M.S./Ph.D. chemist to perform analysis; method development experience desired. "Company benefits include liberal vacation"; there's a joke in there somewhere. No relocation offered.

You gotta love this: In the middle of this paltry assortment of ads, there's an advertisement from the Singapore Economic Development Board, suggesting that chemists or chemical engineers with "passion for academic or industrial research" visit contactsingapore.sg for ads for work there. Following the links will lead you to 11 positions for working chemists, some for quite senior ones. (I've always wanted to see Singapore; I'll have to give up my love of Big League Chew, though.)

Monday, May 16, 2011

Chemists: Not such great geographers

A wonderful little scene unfolded on LinkedIn recently, when a consultant for a San Francisco-based biotech asked:
Can anybody recommend some good Bay Area synthetic chemistry CROs?
Of course, there were four or five people who chimed in with useful suggestions for Bay Area CROs.

At the same time, there has been a wonderful collection of people from around the world throwing their hats in the proverbial ring. So far, we have people suggesting companies located in Seattle, two from Shanghai, the UK, Winnepeg, New Jersey, Delaware, Ontario, two from Bangalore, the Netherlands, Massachusetts, Edmonton (Canada), Milan (Italy), Germany and Kolkata.

While I can't really blame people for trying, I think it speaks to 1) the rather fierce competition for synthetic chemistry business around the world and 2) people's complete inability to police themselves when it comes to making suggestions on internet forums. 'Twas ever thus. 

Friday, May 13, 2011

Grrrrrrrr

Blogger is down, and it ate some posts. Grunt. More soon. 

Thursday, May 12, 2011

MMMMEEEEERRRRRCCCCKKKKKK!

Yeah... you don't seem very Empowered...
Photo credit: brillianceinc.com
Are you a chemist? Do you like doing chemistry? Merck, the pharmaceutical company, would like to know if you want to be a materials handler in Ireland, a command center technician, a statistics intern or a pipefitter. No?

How about an operations coach? What's that, you say? Well, I'm glad you asked. You will:
  • Coach production employees in an Empowered Culture
  • Assist the team with development of objectives and ensures alignment with site goals
  • Assess employee training and development needs, assesses the maturity of the team, and adjusts leadership style to enhance team performance
"Assess the maturity of the team" -- hmmm. If you read between the lines, I think you'll be a (assistant?) manufacturing plant manager. But why in the world couldn't they just call it that? (h/t See Arr Oh)

Daily Pump Trap: 5/12/11 edition

Good morning! Between May 10 and 11, there were 82 new positions posted on the ACS Careers website. Of these, 4 (5%) are academically connected.

Hmmm: Not much here, other than tinned meat from our friends in Rahway (73 position, 89%). Except for...

Fresh! Foods!: BASF is looking for 5 positions, including a B.S. chemist with 5 to 10 years experience in agricultural chemical formulations experience. Also, two positions (one marketing and one solving technical problems) with fresh food solutions.

A broader look: Monster.com, Careerbuilder.com and Indeed.com show (respectively) 308, 728 and 4,324 positions posted for the search term "chemist." USAjobs.gov shows 91 positions for the search term chemist. 

Tuesday, May 10, 2011

Outsourcing: The good, the bad and the ugly

I think it's the bottom one that wants to
send your job to Bangalore.
Photo credit: AJC1
Susan Ainsworth's article in today's C&EN on chemistry outsourcing managers is worth a read. She talks to a lot of knowledgeable people about the process and sheds some light on a relatively mysterious topic.

The Good: There is some small room for knowledgeable, experienced chemists to do some good:
Although the client asked the CRO to follow a synthetic route outlined in the literature, Levy explains, “the contract organization took the liberty of modifying the chemistry to increase the efficiency of the synthesis by minimizing the number of steps and, in the process, ended up reversing where substituents were attached to the structural core.” The CRO made a molecule with exactly the same molecular weight as the desired product and a similar nuclear magnetic resonance spectrum. “That’s the kind of problem that an outsourcing manager without a strong chemistry background will miss,” he warns.
The bad: Sometimes, the things they have to be aware of is just a little basic:
Crystal-clear communication is especially critical when someone “is 12 time zones away,” Kimball says. “When you are in the lab next door, you can walk in and talk to people, and you can touch and feel the process and better understand why a reaction doesn’t work, but when that work is being done remotely, it is much more difficult. Many of the assumptions that we make, having been trained in the U.S., may not be valid. The quality of reagents, laboratory conditions, and the care with which reactions are carried out may not be the same.” 
Kimball recalls an instance when a straightforward Friedel-Crafts acylation reaction following a literature procedure failed repeatedly as it was being carried out by a CRO partner. “Finally, it was determined that the high humidity in the lab and poor storage conditions of the aluminum chloride reagent were at fault. Once those were corrected, the chemistry worked as planned.”
Aaaand the ugly: I'm glad that Kerry Spear (of Sunovion Pharmaceuticals) was willing to be fairly upfront about his thoughts on synthetic chemistry. This is a set of statements that every 1st year graduate student that contemplates a career in synthetic chemistry should think about:
When orchestrating a corporate outsourcing effort, leaders must have a clear understanding of the company’s strategic outsourcing goals and how the drivers—quality, speed, and cost—impact those goals, Spear says. They also need “to recognize what chemistry is best to keep in-house and what could be outsourced,” he adds. For example, “all the things a classical medicinal chemist does we consider core, at least for now, which means we keep them in-house,” he says. “However, we consider synthetic chemistry to be very outsourceable. Frankly, we don’t do any of it in-house anymore.”
I don't really know what do say about that; I mean, sure, I don't make my own TBSCl -- I outsource it to Aldrich (Oakwood, actually, if I have anything to say about it.) But I'd be really interested to hear what Dr. Spear considers 'core' and 'not core'. I'll tell you what -- the 'core' part was probably gotten smaller over the past ten years, as opposed to getting bigger.

Good news / bad news

It is always difficult to tell which way the economy is going -- if I knew, I wouldn't be a bench chemist, that's for sure. I'm instituting a new post series that will combine a piece of undoubtedly good news with something that's potentially bad news. So, without further ado:

Good news from Biospace!: Doubtless, you got the same e-mail from them that I did 3 days ago, stating: 
BioSpace job postings hit the highest volume since December 2008 -- a sure sign of great new opportunities waiting for you. 
Considering that was near the depths of the Great Recession, that's not saying much. But there you are. Good news. How big? No one knows.

Bad news (?) from Paul Hodges: Paul Hodges of the incomparable "Chemicals and the Economy" blog launched "Downturn Alert" last week, noting that commodity chemical prices are beginning to fall, as manufacturers are purchasing less and looking for lower prices. 

Daily Pump Trap: 5/10/11 edition

Good morning! Between May 5 and May 9, there have been 31 new positions posted on the ACS Careers website. Of these, 13 (42%) are academically connected and 1 (3%) is from Kelly Scientific Resources.

Well, that's bracing: "DuPont is a science company. Science is our heritage and our future." In their crop protection labs in Newark, DE, they're looking for a M.S. chemist to become an associate investigator in their analytical chemistry division.

More from the Blue Hen: JAS Inc. is an Agilent subsidiary; they're looking for Ph.D. analytical chemists to work on GC and GC/MS systems. 2 positions; no relocation offered.

Movie villain names: Clontech Laboratories Inc. is looking for a Ph.D. organic chemist with experience in chemical biology. "The candidates will lead the Chemistry Group on the development of chemical compounds (chemical design, synthesis and analysis) for research tool development in life science area." Doesn't the name suggest a secret secret laboratory?

More for the analysts: Honeywell's UOP subsidiary is looking for a senior analytical organic chemist; they desire a Ph.D. chemist with experience in organic reaction mechanisms, GC/MS and LC/MS. 5+ years experience desired (?).

And another one (sort of): The Shepherd Chemical Company is looking for a Ph.D. chemist to run their research laboratories; "[d]emonstrated expertise in inorganic chemistry, solid-state chemistry, small molecule synthesis and/or organometallic chemistry is desirable." Experience with a variety of instrumentation desirable. 

Monday, May 9, 2011

Voices from Wall Street

From last week's C&EN, an article on Amgen's strategies by Lisa Jarvis:
Another area where Amgen draws a line between itself and its peers is its commitment to R&D. Although many competitors have made significant cuts to their research budgets, Sharer said the company will continue to invest 18 to 20% of sales in R&D. “This is not an activity where you cost cut your way to success,” he said. 
Investors, meanwhile, had been hoping to see Amgen focus on cost efficiency in its R&D operations and potentially drop some of its less promising discovery programs. 
Prior to the meeting, Leerink Swann analyst Joshua Schimmer had conducted an in-depth analysis of Amgen’s new drug pipeline and identified compounds that he views as too similar to other drugs in development or too risky. “While we were not disappointed that high R&D spend continues, we were disappointed that there was not a clearer message that more low-value pipeline products we previously identified would be culled and replaced with higher-quality in-licensed and acquired late-stage programs,” he wrote to investors. 
Amgen, however, underscored its success in R&D compared with its competitors and said it is committed to partnering and to making tough decisions about its pipeline. To be successful, Sharer said, Amgen needs to “stop projects when they won’t work, have a risk appetite, … and go outside the company nearly as often as you go inside.”
It's all here, folks, which is kinda fun. You want business types (a MBA, even!) from Wall Street telling CEOs where to spend drug company dollars? You got it. You got CEOs saying that they're not going to cut R&D? You got that, too. Best of luck to Amgen, which does really seem to be one of the few companies that hasn't been swinging the ax recently (although maybe that's just my poor memory.)

I've always wondered: what must it be like to be a stock analyst on the pharmaceutical beat? Does Ian Read quake every time Barbara Ryan opens her mouth to speak on Pfizer stock? I would.

One final, weird note on the major pharmaceutical companies and personal finance and Wall Street: who does Dr. Schimmer and Barbara Ryan represent? Well, to a very minor extent, "future" me. I don't directly own any pharmaceutical stock, but I have a reasonable amount of retirement-oriented money in various index and mutual funds. All of their directors (and employed business analysts, etc.), I'm sure, are breathing down the necks of CEOs of companies that I (directly or indirectly) work for, pushing them to increase profits and cut costs. I am sure this is not the only time that the interests of "Present CJ" and "Future CJ" will conflict.  

Friday, May 6, 2011

The boss is always right, right?

I'm sure everyone is familiar with the 2 rules of dealing with the boss:

Rule 1: The boss is always right.
Rule 2: If the boss is wrong, check Rule 1.

I suggest a few more rules:

Rule 3: If the boss is wrong, you should check again.
Rule 4: If the boss is wrong, the instrument should be recalibrated.
Rule 5: If the boss is wrong, perhaps you can't find his cell phone number to tell him.
Rule 6: If the boss is wrong, maybe you heard wrong.
Rule 7: If the boss is wrong, perhaps the literature is wrong.
Rule 8: If the boss is wrong, we should all look at our shoes.
Rule 9: If the boss is wrong, we should admire the boss' creativity in aligning energetic paradigms!
Rule 10: (Use with great care) If the boss is wrong, we should tell the boss.

Thursday, May 5, 2011

Reader question: how to use LinkedIn?

An astute reader writes:
In the comments of your recent consulting post, a commenter mentioned "If you learn some of the ins and outs of LinkedIn it can be a huge help (no, you don't need to buy the gold membership either). My job search has been enormously more productive because of it." 
Any advice (or perhaps a post) on the best ways to use LinkedIn. I'm a recent graduate. I haven't played with the site much but I have my profile as current as possible. 
What else should one be doing? Joining groups? Joining discussions?
I'll be really honest and say I don't really know. I think it's helpful in a job search to have a fairly informative (but not overly detailed) profile and it is a good idea to update it regularly.

I think joining discussions where you might display relevant technical knowledge would be useful, but to be frank, I've really not seen any discussions of chemistry on LinkedIn where this might be the case.

I have found LinkedIn to be a quite useful repository of information about other people; that's helpful, but I don't really know what good it does, outside of being able to know who works at companies that you want to work at. (I think that's the idea, actually.) This parody video on LinkedIn, by the way, is mildly funny.

Outside of that, I'm pretty much out of ideas. Readers, what say you?

An unusual answer

Pfizer CEO Ian Read, in the Wall Street Journal about his moves with Pfizer research sites:
WSJ: Cutting costs is also part of your growth strategy. You're shutting down Pfizer's laboratory in Sandwich, U.K. Was it inefficient? 
Mr. Read: Sandwich was working in areas where I don't think we were competitive enough. It was in areas of allergy and respiratory and urology, and other areas where I didn't think we had the science, or the competition was ahead of us. And it was better to redirect those resources. 
WSJ: You're also moving scientists from Pfizer's long-time research and development center, in Groton, Conn., up to Cambridge, Mass. Why? 
Mr. Read: Historically, Big Pharma was driven by manufacturing, and very often they put manufacturing sites up on rivers because there was fermentation involved and they needed access [to water]. Now, I think you need to be in centers of innovation and hubs of innovation that are represented by La Jolla, Calif; Boston, Mass; and also in the U.K. in Cambridge.
Rivers? I'm really flummoxed by this answer, even though I (sort of) understand what he is getting at: Groton is where it is (historically) because of now-irrelevant geographical features. That being said, I'm afraid this sort of "we need to be there" logic isn't really historically supported. While geographical isolation isn't good, I'm unconvinced that Pfizer chemists from Groton will somehow be magically more productive or innovative in Boston. Color me unconvinced.

Daily Pump Trap: 5/5/11 edition

Good morning! Between May 3 and May 4, there have been 7 new positions posted on the ACS Careers website. Of these, 1 (14%) position is academically connected and 1 (14%) position is from Kelly Scientific Resources.

Ooof: Not very many positions at all. Sigh.

It's something: Total Petrochemicals is looking for a B.S. chemist to be a senior chromatographer in its La Porte, Texas facility. GC experience desired.

And something more: Kelly Scientific is looking for a B.S. chemist with 5-10 years experience in R&D to perform LC and GPC analysis.

Hey, you kids, get outta here: Bangs Laboratories (a wonderful name, if there was one) is looking for a M.S. or Ph.D. polymer or organic chemist. Desired skills: "Experience in emulsion polymerization, inverse emulsion, oil in water dispersion of polymers, and other related microparticle process technologies." Oh, and "Industry work experience beyond the university setting -- this is a must!!!"

A better bandaid: Adhesives Research, Inc. is looking for a Ph.D. polymer chemist with experience in adhesives research, materials science or wound care adhesives work. How many of those are there?

A broader look: Monster, Careerbuilder and Indeed show 329, 719 and 4,317 positions (respectively) for the search term "chemist." USAjobs.gov show 96 results for the search term "chemist." 

Wednesday, May 4, 2011

14 ways to improve morale

No, really. Sometimes I feel a little bad about the blog and the pall it might cast on folks. (Seriously, I should print T-shirts that say "I stopped reading Chemjobber because it's depressing.")

Try these tips and see if you can put a smile on a coworker's face.
  • Donuts always make people happy (or me, anyway). 
  • The "Never Give Up!" picture is worth a chuckle (sometimes.)
  • A sincere word of encouragement never hurt anyone. 
  • Also, a ready supply of bad jokes helps, too. 
  • Organizing group lunches that allow people to vent is great. 
  • Take responsibility and clean some undesirably messy part of the lab. Don't ask for thanks. 
  • A Friday morning breakfast tradition can be fun. 
  • Owning up to screwing up can really break tension a lot, I think. 
  • Ask people how they are -- and listen. (Don't do this, if you're creepy.)
  • Safe and gentle and very, very rare pranks in the lab are enjoyable.  
  • The "Hang In There" kitten is useful, too. 
  • Taking about your young kids can refocus a tough conversation, sometimes. 
  • Volunteer to do someone else's dishes. That'll make 'em wonder. 
  • A candy dish on your desk helps. 
  • BEER. (Thanks A1227p.)
Now go out there and take on the day!*

*Back to your regularly-scheduled depressingness tomorrow. ;-)

Process Wednesday: drying

In the final set of questions from Kilomentor on scaling up, he asks:
Is there a drying step in the process? If so:
  • Can the drying be done by azeotropic distillation or passing through a molecular sieve plug to avoid solid drying agents? Is there an IPC to determine completion of drying?
It seems like there's ALWAYS a drying step in the process. I've seen the powers of azeotropic drying and I believe (I believe!) that there is mostly likely some way of avoiding drying agents. But what that might entail, of course, is a different matter altogether.

Having a rotary dryer of some sort (or rigging one up) seems to be a cheap solution to the problem of drying powders, but I've suspect that they're scale- or cost-limited as well. Readers, please educate me.  

Tuesday, May 3, 2011

A taste of the good ol' days: ancient CAS Online

Goodness, it's just that easy.
Photo credit: chembase.com
I was flipping through some older literature today, and found a wonderful reminder from March's "Advanced Organic Chemistry" (2001, 5th edition) of the torture pain sheer agony effort it took to search through SciFinder before the graphical interface arrived.
  • "The procedure for building a structure can be long and complex, if the structure is large and complex, but the commands are simple. We will illustrate by building the structure for 3-ethylpiperidine, which uses the most important commands.
  • We begin with the command STRUCTURE. [snip]
  • We will then get the prompt ENTER (DIS), GRA, NOD, BON OR ?
  • GRA is used for putting in rings or chains. We enter GRA R6, DIS [snip]
  • We wish to introduct a two-atom side chain (the Et group), so we enter GRA 3 C2, DIS [snip]
  • [a bunch of clarifying text]
  • To get 3-ethylpiperidine, the atom in the 5 position must be nitrogen. A C can be changed to another element by using NOD (for node), so we now type NOD 5 N, DIS. This changes C-5 to N-5, giving all the atoms in their final positions. 
  • However, the structure is still not complete because the bonds have not been specified [snip], so we type BON ALL SE, DIS and we get our final structure in Figure A.1. 
  • At this point we type END, and get L1 STRUCTURE CREATED. 
Oh, you want to search this structure? Forget it. My fingers are cramping. 

Young ones (myself included), if you ever get tired of older chemists railing about how hard they had it back in the day, think to yourself "they didn't have a structure editor in their SciFinder" and cut 'em a break. (a little one) 

Daily Pump Trap: 5/3/11 edition

Good morning! Between April 26 and May 2, there were 39 new positions posted on the ACS Careers website. Of these, 14 (36%) are academically connected and 1 (3%) is from our friends at Kelly Scientific Resources.

Hmmm: A definite slowdown in the number of positions being posted, if I can go close to a week without posting a DPT and only come up with 39 new positions. (None Merck, though. Thank goodness for small blessings.)

Well, that's nice: A nice slug of US-based positions from our friends at DuPont, six in less than a week. Good news for someone.

Rock, chalk: PROSOCO (of Lawrence, Kansas) is looking for a B.S. chemist with experience or training in cleaning surface chemistry for a position as a formulator. Pays close to or better than the median household income for the county!

Heeeeeey: Ensemble Therapeutics has a position for a M.S/Ph.D. computational chemist. There has GOT to be a laid-off computational chemist with these qualifications: "Experience in supporting medicinal chemists in drug discovery programs and experience of commonly used commercial software and leading academic applications including Pipeline Pilot, Discovery Studio, CHARMM and Catalyst."

And for this one, too: SAIC is the contractor for the NCI's "NCI Experimental Therapeutics (NExT) Program." They wish for a Ph.D. medicinal chemist with "ten (10) years of post-graduate experience, including at least 7 years focusing on discovery and optimization of small molecule New Molecular Entities (NMEs) in pharmaceutical or biotechnology organizations; and minimum 5 years managing complex programs that include outsourcing activities. Extensive medicinal chemistry experience in structure-based drug discovery and iterative drug design." Good luck out there -- I suspect that this is a good one. (I mean, it's a defense contractor -- when was the last time you heard of a defense contractor losing a contract?!?!)

Hey, wait a minute: Kelly Scientific is looking for a Ph.D. medicinal chemist to work on the NCI's "NCI Experimental Therapeutics NExT Program." Hey, that sounds familiar... I think this position is the boss of the last one -- or is it the other way around? I dunno -- I don't speak governmentese. OK, I think I'm going to devote a post in the next week to figuring out all of these recent NIH/NCI positions.

You kids -- get back in line!: Polysciences wants a M.S./Ph.D. synthetic chemist for bench work; "this is a must, we are not interested in candidates who only have university experience." OK, OK, I get it.

Monday, May 2, 2011

An interesting business model

I'm surprised this article by Michael McCoy from last week's Chemical and Engineering News wasn't better covered in the chemblogosphere. Okay, so it's tomorrow's edition. It's a fairly interesting take on the "building block" business for small quantities of pharmaceutical starting materials. There was this little tidbit about a small Chinese company:
Ming Qi is all too aware of this perception. As president of Accela ChemBio, a Shanghai-based building-block supplier, Qi says he struggles to distinguish his company from fly-by-night Chinese competitors. [snip] 
Accela employs more than 90 people, Qi says, 40 of whom are chemists. The company lists about 6,000 compounds, roughly 4,000 of which are in stock at any given time. Accela chemists synthesize almost all of the compounds, Qi adds. 
Although himself a newcomer to the building-block business, Qi is amazed at the stream of new players in China and elsewhere that continue to enter the business. Qi says he used to make his catalog freely available, but after seeing competitors start listing the same compounds he became more selective about posting information online. “We don’t want to make it too easy,” he says.
I've never worked in a situation with compounds that are in stock or out of stock, but it seems to me that 40 chemists to work on 2000 out-of-stock compounds is cutting it a little close. When the customer comes a callin' and it's not in stock, I'll bet it's too late.

Thursday, April 28, 2011

Cardboard boxes

So I've been traveling a bit recently, which explains the spotty posting and odd posting times. Apologies -- hopefully things will settle down by next Monday or so. A list of small useful things (links) to tide you over:
  • Dr. John Borchardt (a longtime ACS career counselor) has been writing a long and methodical approach to job applications over at the ACS Careers Blog. If you're looking for a job, you should really go over there and read them. 
  • The Journal of Failed Chemistry Results? Sign me up for a volume. 
  • Th'Gaussling writes a memo to Aldrich; personally, I'd like to write a few memos to all the chemical suppliers...
  • Matt does a beautiful post in honor of Harry Gray. 
  • I can't watch CSB videos without getting a queasy feeling. 
  • I'm not a big fan of Sour Patch Kids (or any sweet candy, for that matter), but Sharon is. They're full of protons, don't you know.  
See you late tomorrow, I hope. 

Wednesday, April 27, 2011

12 lies told in chemistry


1. That reaction is incredibly clean.
2. Our budget just doesn't have any more room for capital equipment.
3. We just maintained that instrument last month!
4. We have a well-trained staff of emergency responders -- I think we'll be fine.
5. No, we think this department is just the right size. No major changes coming.
6. I really think this molecule is going to be the one.
7. You just need to put a little more effort into that project.
8. Shenzhen ABC Chemical Corporation offers only the finest in materials and reagents.
9. You know, that instrument is really easy to learn to use.
10. You just need to run a few more experiments and then we can publish!
11. This vacuum distillation delivers beautiful material cleanly and quickly.
12. Please tell us what you think -- we're all friends here.

Daily Pump Trap: 4/26/11 edition, SAO version


A guest post from the kind and funny See Arr Oh (thanks, SAO! -- CJ):

Good morning!  From April 21-25, there were 41 new jobs posted on ACS Careers.  Of these 9 (22%) are academically connected, 1 (2%) from Kelly Scientific, and a whopping 20 (49%) from our friends at 
MEEEEEEEERCK!   Any chemists in the audience want to be a Machine Operator in Miami?  Perhaps a Customer Representative in Texas, or a Finance Analyst II in New Jersey?

Speaking of Jersey…Plenty of options for the Greater NY / NJ area this week: BASF is hiring an Analytical Ph.D. in Tarrytown; Anichem, a CRO in New Brunswick, offers a synthetic BS / MS position; and CUNY-Brooklyn wants a computer scientist with possible interests in nanotechnology.

Nothing Could be Finer: Tons of opportunities south of the Mason-Dixon: Imerys (GA), Xavier U. and DuPont (LA), U of Kentucky (KY), Unimin and Novan (NC), and Coastal Carolina University (SC) are all hiring.

Further Afield:  The IISC in Bangalore, India is looking for a physical chemist to study soft matter, energy, and polymers.  Are you a “visionary thinker/innovator” who is fluent in Mandarin and English?  Consider applying to be a scientific director at ScinoPharm Taiwan, Ltd.  If synthetic organic is your passion, maybe try being a postdoc in Warsaw, Poland or Liverpool, England.

Or Maybe Politics is Your Thing?  The American Chemistry Council,  a 139-year-old lobbying group based in Washington, D.C., is searching for a Senior Economist / Director, whose responsibilities might include “developing specific information and materials to support the social, technological and economic benefits of the products of chemistry.”  Time to dust off that MBA…

See Arr Oh is a Ph.D. organic chemist in industry.

Tuesday, April 26, 2011

A modest proposal: Judgement Day (not a week or a month or years)

"Today, I settled all family business, so..."
Photo credit: emulsioncompulsion.com

Rumors of layoffs seem to always overhang the pharmaceutical business -- it seems like, at some companies, there's a slow painful drip of impending cuts. Worse, the pace of cuts seem to be accelerating from once every couple of years to once every few months. These cuts seem to take place in a few awful steps:
  1. Cuts are rumored to take place at some near-future date; often, this date gets delayed. 
  2. Productive higher-level thinking often grinds to a halt as the 'true' date gets closer and everyone waits until the ax has fallen. 
  3. The ax falls: shock, dismay and horror. Survivors' guilt reigns amongst the survivors. The laid-off leave and their absence is felt profoundly. 
  4. Employees say, "Wow, they're now cutting bone, not fat. They can't possibly cut anymore."
  5. After being asked and asked and asked, management says, "We don't plan to make any cuts again for a long, long time..."
  6. Cuts are rumored to take place...
Here's the Chemjobber plan for creating some level of morale in the meantime. It will never get implemented, but what's the harm?:
  1. Management decides that they're going to revisit cuts at some future date, 2 or 3 or (dare I suggest) 4 years in the future. 
  2. Day 1: Management lays waste to their R&D departments, cutting all the people they think they're going to cut in the next 4 years. 
  3. Day 2: Management announces to their workers: "We've cut all the people we're going to cut until October 1, 20XX. Congratulations, you're the new team. You have (whatever) years until we make another decision on layoffs. Breathe easy until then."
  4. After 2 months of survivor's guilt and freaking out, everyone settles down and gets to work, ignoring that future date until it's soon enough to worry. 
This, of course, is a plan that completely ignores the reality that business expectations (shareholders, etc.) in our modern times seem to hold. It will never happen. But I think it would create some space for being able to engender some level of trust and calm among the employees.*

*I suspect that this plan would have all sorts of weird effects on hiring, etc. The pharma world would start to look a lot more like professional sports in its hiring patterns, which I'm not quite sure is a good thing. 

Daily Pump Trap: temporarily on hiatus

The DPT will return soon, when I have a much better internet connection. Sincere apologies. 

Monday, April 25, 2011

Are on-campus interviews a good idea?

Graphic credit: stopsmilingonline
A thread on the Chemistry Reddit talks about how people got their first chemistry job out of college. There was a minor smattering of people filling out applications and folks having phone interviews, etc.

As you can see from my response, I got my first job out of college starting with an on-campus interview. "XYZ Corporation will be visiting on March 1 to interview potential candidates. Interested students can drop off their resumes with the department secretary, etc., etc." I hesitate to say that I aced the interview, just that I didn't throw up on my shoes. One on-site interview later, I had my first chemistry job out of college. It was pretty great, I thought.

It must be terribly difficult for companies to come up with an initial screening process to find candidates for on-site interviews. On-campus interviews rely on the thought that surely, there must be a student here that 1) meets our criteria and 2) has free time to come and visit us. Presumably, phone interviews are somewhat less picky; the thought process is 1) here are people who have expressed the desire to work for us and 2) most people are available by phone.

I think there's something about face-to-face interviewing that people really like, because it's so time consuming and expensive relative to phone interviews. The average on-campus interview lasts 20 or 30 minutes and the interviewer has already spent quite a bit of money to get to the campus itself (plane ticket + hotel room?) Phone interviews might take as long, but the cost can be quite a bit lower. I suspect that the wealth of non-verbal information that you can derive from face-to-face interviewing is worth the extra cost.*

*Of course, the way to test this is to see if on-campus interviewing is more successful at bringing in on-site interview candidates and future employees than phone interviews. 

Friday, April 22, 2011

A handy project management flow chart

I was always a big fan of this flowchart growing up -- now that I'm a little older and I work in chemistry, here's my version. 

Thursday, April 21, 2011

Chart of the week: where did the jobs go? Not in the US, that's for sure.

Chart credit: David Wessel, Wall Street Journal

From an astute reader, the chart of the week: since 2000 until 2009, major United States-based multinational corporations eliminated 2.9 million jobs in the United States. During that same time, they've added 2.4 million jobs overseas.

I doubt that pharmaceutical and chemical companies are responsible for that much of the gap between the two categories. That being said, I can't imagine that they have not contributed at all.

Gee, I hope this works out well for all of us. 

Daily Pump Trap: 4/21/11 edition

Good evening/morning! Between April 19 and April 20, there have been 21 new positions posted on the ACS Careers website. Of these, 5 (24%) are academically connected and 3 (14%) are from our friends at Kelly Scientific Resources.

But what does that mean?: Lilly is looking for a cheminformatics scientist with at least two years experience; among the minimum requirements, "A proven track record in developing novel computational chemistry / cheminformatics methods with a demonstrated impact on drug discovery research." Wow. I think I know what that means, but I'm not positive. I think it's something more than lots of neat looking Spotfire plots, but I could be wrong.

QC Heaven (or is it Hell?): Novan, Inc. is looking for a B.S. chemist to be an analyst. Duties include being "responsible for conducting performance testing on raw materials, drug substance intermediates, active pharmaceutical ingredients (API), and finished dosage forms (FDF)." Sounds like a party.

More for the analysts: Exova's Gary, Indiana lab is looking for a B.S. chemist with some experience with "gas analyzers, a remelting machine and an ARL 3460 spectrometer". You know, if I were a chemist in Gary, Indiana... (amusingly, local candidates are preferred.)

Moooo, Merck: 6 (29%) positions from our friends at Rahway, including a position to become the Senior Territory Representative for Beef Cattle Products in Utah. You know, I'm crazy enough that I think I would enjoy this position. That being said, you don't need a degree in chemistry to do this job -- so why is it being advertised on ACS Careers? (h/t to devoted commenter See Arr Oh.)

Wednesday, April 20, 2011

How many people are leaving the pharmaceutical industry (and why?)

What would a similar chart from the pharma world look like?
Image credit: Falk & Rogers, Harvard/Kennedy School of Government
A recent report from Harvard's Kennedy School of Government looks at the various reasons that relatively young junior officers are leaving the military. Surprisingly (or not), neither operational tempo nor better pay in the civilian world were strong reasons for them to decide to get their DD-214.

It would be really interesting (to me, anyway) to know how many people are voluntarily leaving the pharmaceutical and/or biotech worlds. Where are they going (and why), I wonder? I remember a very promising young bench chemist from my Big Pharma days who decided (months after they were given an internal research award) to start over and head off to the intellectual property world. I sincerely hope that gave the senior management something to think about.

What would be my top 4? Job stability, ability to 'make a difference', company bureaucracy, the outlook for the industry easily come off the top of my head. Readers?

While I don't doubt that the most of the reasons are fairly obvious or well-picked over, it would be a good idea for someone in this industry (or ACS, as if they didn't have enough to do) to find out the numbers, track these folks down and interview them. Scientific data (or pseudo-scientific data) would be enough, I'd think, to end a lot of old arguments and start a lot of new ones. 

Daily Pump Trap: 4/19/11 edition

Good evening! Between April 14 and April 18, there were 105 new positions posted on the ACS Careers website. Of these, 9 (9%) are academically connected.

Taxpayer dollars at work: NIH is hiring a (very experienced) Ph.D.-level medicinal chemist to support NCI's Developmental Therapeutics Program. This is a plum for someone, that's for sure. Nice salary, too.

Da, tovarisch!: 80 (76%) of positions posted were from the latest dump by Merck. It's fairly frustrating to sort through this mess of positions. I'm especially amused by the position that's a sales analytics position in Moscow, Russia. Be sure to pack your funny fur hat.

Inks: ITW Trident is a maker of ink jet printer ink; they're looking for a M.S./Ph.D. chemist who has 10+ years experience in ink formulation. I gotta interview one of these people sometime; readers, know any likely subjects?

You could try a Polish Boy!: Ben Venue Laboratories in Bedford, OH is looking for a B.S. chemist with 5+ years experience in the analytical field. Lots of paperwork, protocol writing and some supervision, looks like.

Huh: Watson Pharmaceuticals is looking for a B.S. chemist with 5-8 years of analytical experience to be a Chemist III on the 2nd shift. That's not something you see every day, shift work for chemists...

Tuesday, April 19, 2011

Daily Pump Trap: Well, not really

Ignore the orange bars; it's the blue bars that are key. Note the drop for the first part of April, with the spike for the recent Merck dump. A real DPT later today, hopefully. 

Monday, April 18, 2011

A reader question: how should a young chemist use their time wisely?


A reader (we'll call them IW) writes in with a question:
I plan to accept a job in a new start up as a chemist. The start up is on a solid platform (well backed by a [important biotech geographical area] VC), so there is no issue about stability for a few years. My question is: how should I use this opportunity to stabilize myself professionally in the drug discovery chemistry field. I am hoping some of your readers might have started their careers in a similar fashion and have some advice for the rough future.
My advice to IW (even though I am not too far from their position is this): attempt to achieve some depth first (really get to know your project and your project's chemistry), and then start to see what kind of breadth you want as well. 

Recent interviews offer good advice: MQ talks about the "building depth" as such:
Keep learning. Take the time to learn as much as you can about the biology going on within your project, especially your primary assays. Talk to the biologists; ask them how they are run, and how to best interpret the data. Talk with the pK folks as well, and anyone else your project interacts with for data. Try to attend as many higher level meetings as you can to get a feel for how the decision making process is handled in your company. Make it a point to go to general informational seminars in other therapeutic areas. Keep learning new things because you just may find yourself transplanted on very short notice.
Kay talks about the importance of keeping up your communication skills (always a difficult thing for somewhat introverted chemists):
Make sure you keep up your writing and presentation skills. When you're busy in the lab, it's easy to brush off writing reports or presenting your work at meetings. But those skills are important in the long term. You can be a terrific bench chemist but if you can't communicate, you will have a hard time getting jobs and advancing in your career. You have to sell your work and you also have to sell yourself. Those skills are also crucial if you ever decide to leave the bench or move into another career.
It's all very difficult and confusing for a young chemist starting out in the industry -- I seem to recall a premed advisor in college (don't ask) saying something like "You know, to get into medical school, it helps to walk on water." But it seems to me that between the learning in the lab, and the learning by talking to people, there will be more than enough opportunity to really start a career on the right track. 


Readers, what do you think? Am I crazy? 

Consulting and volunteering: a tactic for unemployed mid-career chemists?

Today's issue of Chemical and Engineering News has an article by Linda Wang that features the stories of 6 chemists and engineers who found themselves out of work and what they did with their time. (Our friend Daniel Levy is among them.) The common thread? Consulting or otherwise using that time to perform (unpaid) work towards their future employment goals. To wit:
When Ph.D. chemist Steven A. Weissman was laid off from Merck & Co. in 2008, he knew that it would take a while before he found a new job. “I was mentally prepared for a long-term search,” he says. “I had no illusions that it was going to be a one- or two-month thing.” 
"Employers “can have a bias against people whom they perceive to be stale." After allowing himself two weeks to regroup, Weissman immediately got to work. He completed the Mini-MBA program at Rutgers, attended scientific meetings, read scientific publications, served as a coinventor on two patents with former colleagues from Merck, and bolstered his online presence. “You definitely have to answer the question, ‘What have you done with your time in transition? What have you accomplished?’ ” In late 2009, Weissman was offered a job with Concert Pharmaceuticals in Lexington, Mass., where he is now associate director of process chemistry. [snip]
While Ph.D. chemist Paul Young was unemployed after being laid off from Nalco in 2001, he served as an adjunct professor at several colleges in the Chicago area. “My teenage son was making more from his part-time job as a grocery cashier than I did from my part-time job teaching college chemistry,” he recalls. But the experience helped him improve his presentation and public speaking skills. He also kept his mind sharp. “There’s a lot of creativity in teaching when you’re trying to figure out the answer to a good question,” he says. 
During this period, Young also consulted for St. Michael, Minn.-based U.S. Water Services, which provides water treatment services, and it was this work that eventually led to his current full-time position with the company. 
Well, I suppose that's something to remember for unemployed chemists -- on top of searching for a job, you need to try to stay current in your field. Best wishes to all of us.

Friday, April 15, 2011

Goodbye, old girl.

I'll miss you, chariot.
You're not supposed to have a nice car during graduate school, but when I bought this Hyundai in 2003, I thought I had purchased a lovely, lovely vehicle. I took great roadtrips in this little roller skate, wandering all throughout the Midwest in it. I drove it across the plains of Texas and Oklahoma and we took it up into Canada. I wooed my wife-to-be in the front seats and brought my first child home in the back seat.

While cars are mostly a tin box on wheels, they really do become a part of your life, especially when they're one of the few constants in the itinerant life of an young chemist.

Readers, what was your car of graduate school (or was it a bike?)

Chart of the week: a decade's worth of layoffs in Big Pharma


Yesterday, Derek Lowe linked to Matthew Herper's posting of Challenger, Gray and Christmas' listings of ten years of pharmaceutical industry layoffs. I've done the tabulation here.

The chart speaks for itself; Derek notes that he was part of the numbers in 2006. I'll note that for each of the above years after and including 2006, I believe I can name someone I know who was laid off. (Big surprise, really.) A historical (and unfair and possibly inappropriate) comparison: the Battle of Antietam had 23,000 casualties. Operation Overlord is listed with 14,000 to 19,000 casualties (for both sides).

Unfortunately, the numbers don't do a breakdown between R&D and sales forces, etc. But I suspect that it was in 2007 that the site-wide closures (here's looking at you, Ann Arbor) that started really hammering chemistry employment. Of course, there is also churn where people are laid off and immediately rehired elsewhere; this series of comments by Rick puts together a nice summary of that activity.

Best wishes to all of us.

Thursday, April 14, 2011

New poll: post-UCLA academic chemical safety

Quick poll: has academic chemical safety improved since the UCLA/Sangji incident? You can comment if you wish; people (other than me) will be reading.

Which has more job stability: process or medicinal chemistry?


It's a cliché -- sorry. (Photo credit: greatermindz) 
 A devoted reader asks if process chemistry is more stable than medicinal chemistry. To be frank, I really don't know.

Let's not pretend that medicinal chemistry is not slowly being pushed overseas. While some "high-value" medchem might be kept here, it doesn't really appear as if there are plans for large pharmaceutical companies to keep armies (as opposed to regiments or battalions) of senior scientists and associates busy cranking out compounds and submitting them for testing in the United States. I am (as yet) unaware of any Big Pharma CEOs saying, "Oh, yes, we're done outsourcing and it's time for us to make big pushes in drug discovery." So the baseline comparison is looking pretty dire.

At the same time, process chemistry is manufacturing-related and thus much closer to the global trends of offshoring manufacturing. It seems that (for whatever reason) much pharmaceutical manufacturing is done overseas already -- will the process development be far behind? I don't know, but there is one sobering thought: what organization doesn't wish that the medicinal chemists talk earlier and more often with the process R&D folks? Which is easier: coordinating teleconferences across time zones or setting up process R&D in international locations?

The turbulence of the last ~8 years doesn't seem to be ending any time soon in the pharmaceutical industry and it seems that there isn't any "safe" place. Best wishes to all of us.

Daily Pump Trap: 4/14/11 edition

Good morning! Between April 12 and April 13, there were 12 new positions posted on the ACS Careers website. Of these, there are no academically connected positions.

I'm guessing business is good: ATL International is hiring an experienced analytical chemist to run its nuclear forensics lab. Why don't the CSIs of Las Vegas PD have one of those? They seem to have everything else. You'll get to interact with DOE, DHS and FBI -- that'll be fun. (Pays pretty good, looks like.)

Another nickel for my collection: Sigma-Aldrich is looking for a Ph.D. synthetic polymer chemist; it appears that they'd like someone who's worked in the industry, but they'd take a new graduate that had knowledge and/or academic experience in the field.

Working for the man: UES works on "structure/processing/properties relationships in nanostructured materials, polymers, and metamaterials. [They] also investigate materials, processes, and architectures for devices such as sensors, flexible electronics, batteries, capacitors, and solar cells." They're looking for Ph.D. chemists to be postdocs in materials science; experience with SEM, TEM, XRD and XPS desired.

Nano-working for the man: Sandia National Labs is looking for a technical director for its division that looks at "Materials - Nano-materials for energy and national security applications with specific attention given to the Nuclear Weapons SMU." Their "current emphasis includes Nano-structured materials and materials with unique Nano-Enabled Properties." Huh. Experience in the nano-world desired. Good luck with that.

Outsourcing corner: Asian Paints (India) is looking for senior scientists -- they're paying well (I hope) and their benefits are "best in the industry." GSK is looking for an experienced chemist to be a medical chemistry team leader in Shanghai -- I'll bet that's good money these days. Ni hao!